Clinical Research Directory

Inclusion Criteria: * Participants aged 40 to 65 * Newly diagnosed dyslipidemia (two years) with SCORE ≥1 - \<5 (LDL 116 - \<190 mg/dL): Moderate Risk * No indication for pharmacological treatment in primary prevention. * Possibility of performing analytical controls at the beginning/end of the study. * Willingness and capacity to give informed consent. Exclusion Criteria: * Participants with vascular risk requiring pharmacological treatment or high/very high vascular risk. * Participants in secondary prevention. * Hyperthyroidism according to the researcher's criteria. * Taking vitamin B supplements and/or supplements containing polyphenols in the 30 days prior to the screening visit (at the researcher's discretion). * Serious illness with a life expectancy of less than three months. * Known allergies or intolerance to halophytic plants. * Pregnant or breastfeeding women. * Presence of active neoplastic disease. * Having participated in another clinical trial with medicines in the 30 days prior to the screening visit, or intending to do so during your participation in this study. * Regular consumption of halophyte plants. * Participants who, in the researcher's opinion, are not able to comply with the study protocol.